|
|
       |
|
|
|
For Patients on SOMAVERTSOMAVERT® (pegvisomant for injection) is indicated for the treatment of acromegaly in patients who have not responded well to surgery and/or radiation therapy and/or other medical therapies, or for whom these therapies are not appropriate. The goal of treatment is to normalize serum IGF-I levels. Learn more about: Your IGF-I levelsWhile you are on SOMAVERT, your doctor will check your IGF-I levels often. This will show how well your disease is controlled. Your doctor may change your dose to help you achieve normal IGF-I levels. Please see full Prescribing Information and Patient Information. |
Important Information for Patients:SOMAVERT is a medicine used to treat patients who have acromegaly. Do not use SOMAVERT if you are allergic to SOMAVERT or any of its ingredients. The stopper on the vial of SOMAVERT contains latex. Some patients who have used SOMAVERT have developed liver problems. Your doctor may do blood tests before and during your treatment with SOMAVERT to check that your liver is working correctly. The most common side effects with SOMAVERT are pain, infection, reaction at the site of injection, flu symptoms, nausea, and diarrhea. These are not all of the possible side effects of SOMAVERT. For more information, ask your doctor or pharmacist.Be sure to tell your doctor if you use:
For full patient information, click here. Copyright 2006 Pfizer Inc. All rights reserved. GN272936B rev. August 2006 The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. |
|